Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Dr. Jagannath

Home/Tag:Dr. Jagannath
23 02, 2015

Myeloma therapy advances big and small

Tags: , , , |12 Comments

Speaking of new treatment options, here's an excerpt from an excellent summary of what I consider to be "stopgap" myeloma therapy measures until new immunotherapy technology moves front and center: Treatment Triplets Offer New Strategies in Relapsed Multiple Myeloma Anita T. Shaffer - OncLive.com Published Online: Friday, February 20, 2015 The treatment options for patients

15 07, 2013

HDAC inhibitors work great in the lab. Why not better in patients?

Tags: , , , , , |2 Comments

This weekend I shared how I was becoming anxious and frazzled with the added responsibility and concern for my dying father.  The mental and emotional health of myeloma patients and caregivers is an under-served and rarely addressed part of our lives.  You know me; I'm not going to let this go.  I will get back

9 02, 2013

Everything you always wanted to know about POM but were afraid to ask…

Tags: , , , , , , , , , , , , |4 Comments

The internet is flooded with excitement following the FDA's limited approval of celgene's newest IMiD, pomalidomide (trade name, POMALYST).  POM is an analogue of thalidomide (trade name, Thalomid).  Researchers actually developed POM before Revlimid, but sat on it for a decade--choosing to intensify clinical study activity recently, culminating in yesterday's FDA approval. I'm going to

1 02, 2013

mSMART, OS update and inspirational friends

Tags: , , , , , |3 Comments

Let's start with a helpful link to Mayo Clinic's Medical Laboratory site: Multiple Myeloma Proper Diagnosis and Risk Stratification to Guide Treatment Here you will find an informative video and helpful charts that help explain how genetic testing works, and why Risk-Adapted Therapy (mSMART ) is an important tool for myeloma specialists. Next, listen to

14 04, 2012

Another new myeloma antibody continues to impress…

Tags: , , , , |14 Comments

Here is some follow-up on a more well tested anti-myeloma antibody, Elotuzumab--the kind of therapy you will find featured in my new myeloma therapies book. A number of top myeloma experts, including Doctors Jakubowiak, Jagannath, Durie and Orlowski are big fans. This article is from an online trade publication called OncLive.com: Elotuzumab Responses High in